Document is current
Any future updates will be listed below
-
Authors
Skarin, Angelika https://orcid.org/0000-0003-0181-1692
Berthold, Elisabet
Rauer, Ola
Bengtsson-Stigmar, Elisabeth
-
Funding
Funding for this research was provided by:
Stiftelsen för Synskadade i f.d. Malmöhus län (-)
Skånes universitetssjukhus (-)
Ögonfonden (-)
Svenska Läkaresällskapet (-)
Lund University
- License Information
-
More Information
Article History
Received: 22 March 2022
Accepted: 14 June 2022
First Online: 8 July 2022
Declarations
:
: The study was performed in accordance with the Helsinki Declaration. It was approved by the Regional Ethical Review Board for southern Sweden (2017/263) and the National Ethical Review Agency (2020–02134). Written consent to review ophthalmic medical records were received from all individuals participating in this study.
: Not applicable.
: The authors report no conflict of interests. The authors alone are responsible for the content and writing of this paper. AS has previously served as an advisor for Santen Pharma AB, Sweden and has given lectures funded by AbbVie AB, Sweden.
